Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice
Open Access
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 71 (1) , 153-162
Abstract
No abstract availableKeywords
Funding Information
- Metakids
This publication has 46 references indexed in Scilit:
- AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat liversGene Therapy, 2011
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Liver Transplantation in Children With Progressive Familial Intrahepatic CholestasisTransplantation, 2007
- Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal ratsGene Therapy, 2005
- Spontaneous cholecysto- and hepatolithiasis in Mdr2 −/− mice: A model for low phospholipid-associated cholelithiasis†Hepatology, 2004
- Hepatocyte-specific expression of the human MDR3 P -glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (−/−) miceHepatology, 1998
- Ursodeoxycholic Acid Therapy in Pediatric Patients With Progressive Familial Intrahepatic CholestasisHepatology, 1997
- Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse.Journal of Clinical Investigation, 1995
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseaseCell, 1993
- Sirius Red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liverLiver International, 1990